Article
Reference
Coronavirus disease (COVID-19): a scoping review
LV, Meng, et al. & the COVID-19 evidence and recommendations working group
Abstract
BackgroundIn December 2019, a pneumonia caused by a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China and has rapidly spread around the world since then.AimThis study aims to understand the research gaps related to COVID-19 and propose recommendations for future research.MethodsWe undertook a scoping review of COVID-19, comprehensively searching databases and other sources to identify literature on COVID-19 between 1 December 2019 and 6 February 2020. We analysed the sources, publication date, type and topic of the retrieved articles/studies.ResultsWe included 249 articles in this scoping review.
More than half (59.0%) were conducted in China. Guidance/guidelines and consensuses statements (n = 56; 22.5%) were the most common. Most (n = 192; 77.1%) articles were published in peer-reviewed journals, 35 (14.1%) on preprint servers and 22 (8.8%) posted online. Ten genetic studies (4.0%) focused on the origin of SARS-CoV-2 while the topics of molecular studies varied. Nine of 22 epidemiological studies focused on estimating the basic reproduction number of COVID-19 infection (R0). Of all identified [...]
LV, Meng, et al . & the COVID-19 evidence and recommendations working group. Coronavirus disease (COVID-19): a scoping review. Euro Surveillance , 2020, vol. 25, no. 15, p. 2000125
DOI : 10.2807/1560-7917.ES.2020.25.15.2000125 PMID : 32317050
Available at:
http://archive-ouverte.unige.ch/unige:151709
Disclaimer: layout of this document may differ from the published version.
1 / 1
Supplement S1 Search Strategy
"This supplementary material is hosted by Eurosurveillance as supporting information alongside the article [Coronavirus disease (COVID-19): a scoping review], on behalf of the authors, who remain responsible for the accuracy and appropriateness of the content. The same standards for ethics, copyright, attributions and permissions as for the article apply. Supplements are not edited by Eurosurveillance and the journal is not responsible for the maintenance of any links or email addresses provided therein."
MEDLINE
#1. ‘Wuhan coronavirus’ [Supplementary Concept]
#2. ‘novel coronavirus’[Title/Abstract]
#3. ‘Wuhan virus’[Title/Abstract]
#4. ‘Wuhan-Cov’[Title/Abstract]
#5. ‘Wuhan seafood market pneumonia virus’[Title/Abstract]
#6. ‘2019-CoV’[Title/Abstract]
#7. ‘2019-nCoV’[Title/Abstract]
#8. ‘2019 novel coronavirus’[Title/Abstract]
#9. ‘COVID-19’ [Supplementary Concept]
#10. ‘Novel CoV’[Title/Abstract]
#11. ‘SARS-CoV-2’[Title/Abstract]
#12. ‘novel coronavirus pneumonia’[Title/Abstract]
#13. ‘severe acute respiratory syndrome coronavirus 2’ [Supplementary Concept]
#14. OR/#1-#13
#15. ‘2019/12/01’[Date - Publication] : ‘2020/02/06’[Date - Publication])
#16. #14 AND #15
Web of Science
#1. Topic: (COVID-19)
#2. Topic: (Wuhan coronavirus)
#3. Topic: (novel coronavirus)
#4. Topic: (Wuhan virus)
#5. Topic: (Wuhan-Cov)
#6. Topic: (Wuhan seafood market pneumonia virus)
#7. Topic: (2019-CoV)
#8. Topic: (2019-nCoV)
#9. Topic: (2019 novel coronavirus)
#10. Topic: (Novel CoV)
#11. Topic: (SARS-CoV-2)
#12. Topic: (novel coronavirus pneumonia)
#13. Topic: (severe acute respiratory syndrome coronavirus 2)
#14. OR/#1-#13
#15. Limted publish year 2020
#16. #14 AND #15
Embase
#1. ' severe acute respiratory syndrome coronavirus 2'/exp
#2. ' COVID-19'/exp
#3. ‘Wuhan coronavirus’ :ab,ti
#4. ‘novel coronavirus’ :ab,ti
#5. ‘Wuhan virus’ :ab,ti
#6. ‘Wuhan-Cov’ :ab,ti
#7. ‘Wuhan seafood market pneumonia virus’ :ab,ti
#8. ‘2019-CoV’ :ab,ti
#9. ‘2019-nCoV’ :ab,ti
#10. ‘2019 novel coronavirus’ :ab,ti
#11. ‘COVID-19’ :ab,ti
#12. ‘Novel CoV’ :ab,ti
#13. ‘SARS-CoV-2’ :ab,ti
#14. ‘novel coronavirus pneumonia’ :ab,ti
#15. ‘severe acute respiratory syndrome coronavirus 2’ :ab,ti
#16. OR/#1-#15
#17. lim 2020
#18. #16 AND #17
#19. #18/medline
#20. #18 NOT #19
CNKI (https://www.cnki.net)
#1. "新型冠状病毒"[主题]
#2. "2019-nCoV"[主题]
#3. "2019-CoV"[主题]
#4. "COVID-19"[主题]
#5. "武汉冠状病毒"[主题]
#6. "SARS-CoV-2"[主题]
#7. "武汉肺炎"[主题]
#8. "新冠肺炎"[主题]
#9. OR/#1-#8
#10. lim 2019.12.1~2020.2.6
#11. #9 AND #10
Wanfang Data (http://www.wanfangdata.com.cn/index.html)
#1. "新型冠状病毒"[主题]
#2. "2019-nCoV"[主题]
#3. "2019-CoV"[主题]
#4. "COVID-19"[主题]
#5. "武汉冠状病毒"[主题]
#6. "SARS-CoV-2"[主题]
#7. "武汉肺炎"[主题]
#8. "新冠肺炎"[主题]
#9. OR/#1-#8
#10. lim 2019.12.1~2020.2.6
#11. #9 AND #10
CBM (http://www.sinomed.ac.cn)
#1. "2019冠状病毒"[常用字段:智能]
#2. "新型冠状病毒"[常用字段:智能]
#3. "新冠肺炎"[常用字段:智能]
#4. "2019-nCoV"[常用字段:智能]
#5. "SARS-CoV-2"[常用字段:智能]
#6. "Novel coronavirus"[常用字段:智能]
#7. "nCoV"[常用字段:智能]
#8. "Emerging Coronaviruses"[常用字段:智能]
#9. "new coronavirus"[常用字段:智能]
#10. "COVID-19"[常用字段:智能]
#11. "coronavirus"[常用字段:智能]
#12. OR/#1-#11
#13. 2020-2020[日期]
#14. #12 AND #13
